CIT GAP BioLife is a private equity general partner firm headquartered in Herndon, VA, United States.
CIT Gap Funds has invested an undisclosed amount in US-based cancer vaccine developer PhosImmune.
CIT GAP Funds has invested an undisclosed amount in US-based pharmaceutical startup Riogin.
CIT has arranged a $50m senior credit facility for US-based medical equipment provider QMES.
Read more news concerning CIT GAP BioLife
A sampling of CIT GAP BioLife portfolio companies:
View all of the investments in their portfolio
This firm also pursues other investment strategies:
Registration is fast, free and easy
Already a member?